www.law360.com/cases/5ad8feff314183143b000001

Sep 19, 2018 ... Parties, docket activity and news coverage of federal case PERRI v. NOVARTIS PHARMACEUTICALS CORPORATION et al, case number ...

www.law360.com/cases/5c36317535af535c0a1268a7

Parties, docket activity and news coverage of federal case SUN PHARMACEUTICAL INDUSTRIES LIMITED v. NOVARTIS PHARMACEUTICALS CORP. et al, ...

www.cafc.uscourts.gov/sites/default/files/opinions-orders/17-2284.Opinion.12-7-2018.pdf

Dec 7, 2018 ... JANE M. LOVE, Gibson, Dunn & Crutcher LLP, New. York, NY, argued for all plaintiffs-appellees. Plaintiffs- appellees Novartis AG, Novartis Pharmaceuticals Corpo- ration also represented by ROBERT. TRENCHARD;.

sanfordheisler.com/case/novartis-pharmaceutical-gender-discrimination-class-action

Case Type: Gender Discrimination Company: Novartis Pharmaceuticals. Amy Velez, et al., v. Novartis Pharmaceuticals Corp. In the largest gender discrimination ...

insight.rpxcorp.com/litigation_documents/12988080

Jul 16, 2018 ... Novartis Pharmaceuticals Corporation is a corporation organized and existing under the .... Bristol-Meyers Squibb Company et al. v. Accord ...

law.justia.com/cases/federal/district-courts/delaware/dedce/1:2015cv00150/56637/187

Novartis AG et al v. Ezra Ventures LLC, No. 1:2015cv00150 - Document 187 (D. Del. 2016) case opinion from the District of Delaware US Federal District Court.

www.clearinghouse.net/chDocs/public/EE-NY-0210-0008.pdf

Amy VELEZ et al. Plaintiffs, v. NOVARTIS CORPORATION et al. Defendants. No. 04 Civ. 9194(GEL). ... (S.D.N.Y.2002), citing Gibson, Dunn & Crutcher LLP v.

www.gibsondunn.com/2015-year-end-fda-and-health-care-compliance-and-enforcement-update-drugs-and-devices

Jan 19, 2016 ... [13] Novartis' Corporate Integrity Agreement stemmed from the ... Streck v. Allergan, Inc., et al., No. 08-cv-5135 (E.D. Pa.). The Streck case ...

www.lmglifesciences.com/general/GEJILYIF

Gibson Dunn & Crutcher attorney Ryan Murr represented Arrowhead ... of Arrowhead earlier in 2016 in gaining the rights to Novartis' RNAi platform technology that is particularly ..... GlaxoSmithKline LLC et al v Teva Pharmaceuticals USA Inc.